India, March 5 -- B2B manufacturing unicorn Zetwerk has raised INR 43 Cr (around $5 Mn) in a funding round co-led by Arc Investments and Oriental Biotech Limited.

The company's board passed a special resolution on February 25 to raise the sum through issuance of 9,93,721 Series F3 compulsorily convertible preference shares (Series F3 CCPS) at an issue price of INR 432.718 per share, as per its regulatory filings accessed by Inc42.

Arc Investments and Oriental Biotech infused INR 10 Cr each in the IPO-bound company, while Stargazer Fund-I invested INR 5 Cr. The remaining capital came from a group of angel investors.

Zetwerk did not say why it has raised the fresh capital. Inc42 has reached out to the company for comments. The story will...